Amanote Research
Register
Sign In
Absence of Tyrosine Kinase Mutations in Japanese Colorectal Cancer Patients
Oncogene
- United Kingdom
doi 10.1038/sj.onc.1210007
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
October 2, 2006
Authors
R-X Shao
N Kato
L-J Lin
R Muroyama
M Moriyama
T Ikenoue
H Watabe
M Otsuka
B Guleng
M Ohta
Y Tanaka
S Kondo
N Dharel
J-H Chang
H Yoshida
T Kawabe
M Omata
Publisher
Springer Science and Business Media LLC
Related search
Germline Mutations in Japanese Familial Pancreatic Cancer Patients
Oncotarget
Oncology
Kinase Mutations in Cancer
Genome Biology
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase Through Multiple Mechanisms
Biochemistry
Biochemistry
Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica
Hematology
Elucidating the Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer Patients
Canadian Journal of Biotechnology
Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer
Experimental & Molecular Medicine
Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer
Journal of the Siena Academy of Sciences
Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated With First-Line Tyrosine Kinase Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
